The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2023

Filed:

May. 23, 2018
Applicant:

Creative Medical Technologies, Inc., Phoenix, AZ (US);

Inventors:

Thomas Ichim, San Diego, CA (US);

Amit Patel, Salt Lake City, UT (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/073 (2010.01); C12N 5/078 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0605 (2013.01); C12N 5/0634 (2013.01); C12N 2501/01 (2013.01); C12N 2501/115 (2013.01); C12N 2501/13 (2013.01); C12N 2501/2302 (2013.01); C12N 2502/025 (2013.01); C12N 2502/11 (2013.01); C12N 2533/50 (2013.01);
Abstract

Disclosed are means, methods, and compositions of matter useful for treatment of neuroinflammation, autoimmunity, transplant rejection, or graft versus host disease (GVHD) comprising exposing autologous immune cells to allogeneic amniotic fluid derived stem cells. In one embodiment peripheral blood mononuclear cells are cultured in the presence of amniotic fluid stem cells in the presence of interleukin-2 for a period of time sufficient to endow tolerogenic properties. Said tolerogenic properties include ability to suppress adaptive or innate immune responses. In another embodiment the invention provides methods of generating antigen specific immune regulatory cells by culture of lymphocytes together with amniotic fluid stem cells in the presence of antigen to which specific immune regulation is desired.


Find Patent Forward Citations

Loading…